# Pegintron Induction Therapy in HCV Non-Responders

> **NCT00363259** · PHASE3 · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 110 (—)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Peginterferon alfa-2b
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00363259
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 110 (—)
- **Last updated:** 2006-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00363259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00363259, "Pegintron Induction Therapy in HCV Non-Responders". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT00363259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*